Orion Corporation

This article is about the pharmaceutical company. For other companies named Orion, see Orion (disambiguation).
Orion Oyj
Julkinen osakeyhtiö
Traded as Nasdaq Helsinki: ORNBV
Industry Pharmaceutical industry
Founded 1917
Headquarters Espoo, Finland
Key people
Timo Lappalainen (President and CEO), Hannu Syrjänen (Chairman)
Products Pharmaceuticals, active pharmaceutical ingredients and diagnostic tests
Revenue €1006.9 million (2013)[1]
€267.7 million (2013)[1]
Profit €206.2 million (2013)[1]
Total assets €979.0 million (2013)[1]
Total equity €513.9 million (2013)[1]
Number of employees
3,519 (2013)[1]
Website www.orion.fi

Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a Finnish company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company also has a large R&D unit in Turku.

Orion's class A and B shares are listed on the Helsinki Stock Exchange.


This list is incomplete; you can help by expanding it.
  • Cardiovascular drugs


This article is issued from Wikipedia - version of the 10/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.